Scientists find key cues to regulate bone-building cells

February 2, 2017 by Terry Devitt
Micrographs show the difference between treated and untreated bone cells in a mouse model of severe bone loss. Wisconsin researchers have identified two native protein factors that help keep mesenchymal stem cells -- the master cells that make bone and cartilage -- happy in the laboratory dish. The work could one day help make regenerating lost bone in patients a reality. Credit: Wan-Ju Li

The prospect of regenerating bone lost to cancer or trauma is a step closer to the clinic as University of Wisconsin-Madison scientists have identified two proteins found in bone marrow as key regulators of the master cells responsible for making new bone.

In a study published online today (Feb. 2, 2017) in the journal Stem Cell Reports, a team of UW-Madison scientists reports that the proteins govern the activity of mesenchymal stem cells—precursor cells found in marrow that make bone and cartilage. The discovery opens the door to devising implants seeded with cells that can replace bone tissue lost to disease or injury.

"These are pretty interesting molecules," explains Wan-Ju Li, a UW-Madison professor of orthopedics and biomedical engineering, of the proteins lipocalin-2 and prolactin. "We found that they are critical in regulating the fate of mesenchymal stem cells."

Li and Tsung-Lin Tsai, a UW-Madison postdoctoral researcher, scoured donated human bone marrow using high-throughput protein arrays to identify proteins of interest and then determined the activity of mesenchymal stem cells exposed to the proteins in culture. A goal of the study, says Li, is to better understand the bone marrow niche where mesenchymal stem cells reside in the body so that researchers can improve culture conditions for growing the cells in the lab and for therapy.

The Wisconsin researchers found that exposing mesenchymal stem cells to a combination of lipocalin-2 and prolactin in culture reduces and slows senescence, the natural process that robs cells of their power to divide and grow. Li says keeping the cells happy and primed outside the body, but reining in their power to grow and make until after they are implanted in a patient, is key.

The ability to precisely manipulate mesenchymal stem cells in the laboratory dish and keep them poised to divide and form bone on cue helps pave the way for using cell-bearing three-dimensional matrices to reconstruct large swaths of bone lost to tumors or major trauma. Because bone has some natural healing properties, things like breaks and fractures can often mend themselves. But when large pieces of bone are lost, clinical intervention is required.

"We're seeking better treatments for ," says Li, who is affiliated with the UW School of Medicine and Public Health.

To engineer the growth of new bone in the body through regenerative medicine first requires generating large amounts of good quality cells in the lab, notes Li. In the body are rare. But if cell growth, differentiation and quality can be controlled in the lab dish, it may be possible to create stocks of cells for therapeutic applications and prime them for once implanted in a patient.

The Wisconsin team successfully tested human cells treated with lipocalin-2 and prolactin to regrow bone by implanting them in mice with a calvarial defect, where part of the skullcap has been surgically removed to model critical-sized bone loss.

The human marrow used in the new Wisconsin study was donated by patients undergoing hip replacement surgery. Thus, a caveat to the study is that the protein factors identified by Li and his colleague came from donors with osteoarthritis. However, Li expressed confidence that the factors from the marrow used in the study would be similar or identical to what occurs in a healthy patient.

The new study, says Li, demonstrates a key improvement to the lab culture environment, which seeks to mimic the marrow niche where are found in the body.

Explore further: Researchers take step toward understanding how multiple myeloma takes hold

Related Stories

Researchers take step toward understanding how multiple myeloma takes hold

October 3, 2016
Israeli scientists are moving closer to understanding how multiple myeloma takes hold in bone marrow by identifying what they believe are the mechanisms used by cancer cells to take over. In particular, they have found that ...

Bone marrow inflammation predicts leukemia risk

October 3, 2016
Cancer is generally thought to arise from genetic damage within individual cells, but recent evidence has suggested that abnormal signaling in the surrounding tissue also plays an important role. In a study published September ...

Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy

November 18, 2013
Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection (TESI) with autologous mesenchymal stem cells and ...

Recommended for you

Researchers describe mechanism that underlies age-associated bone loss

September 22, 2017
A major health problem in older people is age-associated osteoporosis—the thinning of bone and the loss of bone density that increases the risk of fractures. Often this is accompanied by an increase in fat cells in the ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.